When the New York Times editorial board starts sounding the alarm about a cause it spent over a decade championing, something has clearly gone wrong. America now faces an escalating marijuana daily use crisis that many advocates once insisted would never materialise.

The same editorial board that ran a full series pushing for marijuana legalisation more than ten years ago published a stark reversal this week. It acknowledged that its earlier predictions were, in its own words, simply wrong. Legalisation drove far greater use than anyone anticipated. The health consequences are no longer easy to ignore.

Marijuana Daily Use Has Reached Record Numbers

The scale of marijuana daily use in the United States has grown to a degree that few would have predicted even a decade ago. Surveys suggest that roughly 18 to 20 million Americans now consume cannabis on a near-daily basis, around five times a week or more. That figure stood at six million in 2012 and fewer than one million in 1992.

More Americans now use marijuana daily than alcohol. That single statistic cuts through the noise of the policy debate.

The Times editorial board put it plainly: “Legalisation has led to much more use… It is time to acknowledge reality and change course.”

Cannabis Use Disorder Is Far More Common Than Promised

Legalisation advocates long insisted that cannabis carried little meaningful addiction risk, especially compared to alcohol or opioids. That argument has not aged well.

Research from Yale Medicine shows that 30% of cannabis users meet the clinical criteria for addiction. Cannabis use disorder is a recognised medical condition. It now affects millions of people across the country, and the numbers keep climbing.

Kevin Sabet, president and CEO of Smart Approaches to Marijuana, said the outcome was entirely predictable. “If you make a powerful addictive drug easier to access and send the signal that it’s OK to use in the process, more people are going to use it,” he told The Daily Wire. “That is what I and many other people warned would happen and it is precisely what did happen.”

Health Consequences of Marijuana Daily Use Keep Growing

Beyond addiction, cannabis use disorder now connects to a range of serious health outcomes. Advocates largely downplayed these risks during the push for legalisation.

Research in Psychological Medicine found that cannabis use disorder accounts for up to 30% of schizophrenia cases in young men. That finding deserved far more attention than it received.

Heavy marijuana daily use also raises the risk of cannabinoid hyperemesis syndrome. This condition causes severe nausea, vomiting, and abdominal pain. Many users end up in emergency departments repeatedly before doctors identify cannabis as the cause.

A study from UC San Diego School of Medicine and NYU Grossman School of Medicine found that regular cannabis users miss work at higher rates than non-users. That points to a real economic cost that rarely enters the legalisation conversation.

Driving fatalities involving marijuana also skyrocketed between 2000 and 2018, according to data highlighted by Smart Approaches to Marijuana. That period tracks almost exactly with the spread of state-level legalisation.

What Policymakers Knew and Ignored

Some of this evidence was available long before legalisation spread. A 2014 paper by researchers Hefei Wen, Jason M. Hockenberry, and Janet R. Cummings found that legalisation already linked to increased marijuana abuse, dependence, and rising adolescent experimentation. That research existed. Policymakers did not act on it.

Editorial voices and policy advocates chose to describe cannabis as relatively harmless. In many cases, that meant picking a preferred narrative over the data sitting right in front of them.

Youth and Marijuana Daily Use: The Prevention Gap

Legalisation advocates repeatedly promised that regulated markets would keep cannabis away from minors. Federal data now shows that youth marijuana daily use has risen across the national aggregate and within individual states that moved to legalise.

Sabet argued that states must now commit to sustained prevention campaigns and public awareness infrastructure. “States need to focus on making sure that people, and above all young people, know how dangerous and destructive marijuana is,” he said. The window for early intervention is narrowing.

Federal Policy Catches Up to the Crisis

The Times reversal lands at a complicated moment for federal drug policy. In December, President Donald Trump signed an order opening the door to reclassifying marijuana from Schedule I to Schedule III. Schedule III covers substances with a moderate to low potential for dependence.

That reclassification would not legalise cannabis at the federal level. It would reduce the severity of marijuana-related federal offences. Nearly 50 organisations wrote to the administration urging it to keep the Schedule I classification. They argued that cannabis clearly fits the definition and that every formal scheduling review before 2023 reached the same conclusion.

A Reckoning the Data Demands

This moment matters not just because of the statistics, striking as they are. A conversation that many treated as settled has reopened. The people reopening it are not fringe voices. They are some of the same figures who pushed hardest for legalisation in the first place.

The facts now cut across political lines. Marijuana daily use has risen sharply. Cannabis use disorder is real, widespread, and causing serious harm. Young people are using at higher rates. The public health system was never built to absorb any of it.

The question is whether policymakers and communities will take that evidence seriously and act before the damage deepens further.

Source: dailywire